Stroke in Human Immunodeficiency Virus-infected Individuals in Sub-Saharan Africa (SSA): A Systematic Review

Amir Abdallah, Jonathan L. Chang, Cumara B. O'Carroll, Abdu Musubire, Felicia C. Chow, Anthony L. Wilson, Mark J. Siedner

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: Human immunodeficiency virus (HIV) infection is associated with worse outcomes after stroke, but this association is less well-described in sub-Saharan Africa (SSA). We reviewed literature on stroke among people living with HIV (PLWH) in SSA. Methods: We systematically reviewed published literature for original clinical stroke studies conducted in SSA that included PLWH. We included studies that reported data on presenting characteristics, risk factors, and/or outcomes after stroke. Results: Seventeen studies (N = 478) met inclusion criteria. At the time of stroke presentation, PLWH had a median age ranging from 32 to 43 years. Subjects had low CD4 counts (median CD4, 108-225 cells/µl), and most were antiretroviral therapy-naïve. Fever, seizures, and concurrent opportunistic infections were common at presentation. Ischemic stroke accounted for up to 96% of strokes, which were mostly located in the anterior circulation territory. In studies comparing PLWH with HIV-uninfected individuals, PLWH had more frequent coagulopathy, greater stroke severity, (72% versus 36% National Institutes of Health Stroke Scale >13, P =.02), longer hospital length of stay (30.5 versus <10 days), and a higher 30-day mortality rate (23% versus 10.5%, P =.007). Conclusion: Stroke in PLWH in SSA occurs at a young age, in those with advanced disease, and is associated with worse outcomes than in HIV-uninfected comparators. Stroke in young individuals in the region should prompt HIV testing, and ongoing efforts to promote early antiretroviral therapy initiation might also help decrease stroke incidence, morbidity, and mortality in the region.

Original languageEnglish (US)
JournalJournal of Stroke and Cerebrovascular Diseases
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Africa South of the Sahara
Stroke
HIV
Length of Stay
Febrile Seizures
Mortality
Opportunistic Infections
National Institutes of Health (U.S.)
Virus Diseases
CD4 Lymphocyte Count
Secondary Prevention

Keywords

  • HIV infection
  • outcomes
  • risk factors
  • Stroke
  • sub-Saharan Africa

ASJC Scopus subject areas

  • Surgery
  • Rehabilitation
  • Clinical Neurology
  • Cardiology and Cardiovascular Medicine

Cite this

Stroke in Human Immunodeficiency Virus-infected Individuals in Sub-Saharan Africa (SSA) : A Systematic Review. / Abdallah, Amir; Chang, Jonathan L.; O'Carroll, Cumara B.; Musubire, Abdu; Chow, Felicia C.; Wilson, Anthony L.; Siedner, Mark J.

In: Journal of Stroke and Cerebrovascular Diseases, 01.01.2018.

Research output: Contribution to journalArticle

Abdallah, Amir ; Chang, Jonathan L. ; O'Carroll, Cumara B. ; Musubire, Abdu ; Chow, Felicia C. ; Wilson, Anthony L. ; Siedner, Mark J. / Stroke in Human Immunodeficiency Virus-infected Individuals in Sub-Saharan Africa (SSA) : A Systematic Review. In: Journal of Stroke and Cerebrovascular Diseases. 2018.
@article{883d3198b9274eaea1e2cd3ed5f604f5,
title = "Stroke in Human Immunodeficiency Virus-infected Individuals in Sub-Saharan Africa (SSA): A Systematic Review",
abstract = "Background: Human immunodeficiency virus (HIV) infection is associated with worse outcomes after stroke, but this association is less well-described in sub-Saharan Africa (SSA). We reviewed literature on stroke among people living with HIV (PLWH) in SSA. Methods: We systematically reviewed published literature for original clinical stroke studies conducted in SSA that included PLWH. We included studies that reported data on presenting characteristics, risk factors, and/or outcomes after stroke. Results: Seventeen studies (N = 478) met inclusion criteria. At the time of stroke presentation, PLWH had a median age ranging from 32 to 43 years. Subjects had low CD4 counts (median CD4, 108-225 cells/µl), and most were antiretroviral therapy-na{\"i}ve. Fever, seizures, and concurrent opportunistic infections were common at presentation. Ischemic stroke accounted for up to 96{\%} of strokes, which were mostly located in the anterior circulation territory. In studies comparing PLWH with HIV-uninfected individuals, PLWH had more frequent coagulopathy, greater stroke severity, (72{\%} versus 36{\%} National Institutes of Health Stroke Scale >13, P =.02), longer hospital length of stay (30.5 versus <10 days), and a higher 30-day mortality rate (23{\%} versus 10.5{\%}, P =.007). Conclusion: Stroke in PLWH in SSA occurs at a young age, in those with advanced disease, and is associated with worse outcomes than in HIV-uninfected comparators. Stroke in young individuals in the region should prompt HIV testing, and ongoing efforts to promote early antiretroviral therapy initiation might also help decrease stroke incidence, morbidity, and mortality in the region.",
keywords = "HIV infection, outcomes, risk factors, Stroke, sub-Saharan Africa",
author = "Amir Abdallah and Chang, {Jonathan L.} and O'Carroll, {Cumara B.} and Abdu Musubire and Chow, {Felicia C.} and Wilson, {Anthony L.} and Siedner, {Mark J.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.jstrokecerebrovasdis.2018.02.016",
language = "English (US)",
journal = "Journal of Stroke and Cerebrovascular Diseases",
issn = "1052-3057",
publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Stroke in Human Immunodeficiency Virus-infected Individuals in Sub-Saharan Africa (SSA)

T2 - A Systematic Review

AU - Abdallah, Amir

AU - Chang, Jonathan L.

AU - O'Carroll, Cumara B.

AU - Musubire, Abdu

AU - Chow, Felicia C.

AU - Wilson, Anthony L.

AU - Siedner, Mark J.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Background: Human immunodeficiency virus (HIV) infection is associated with worse outcomes after stroke, but this association is less well-described in sub-Saharan Africa (SSA). We reviewed literature on stroke among people living with HIV (PLWH) in SSA. Methods: We systematically reviewed published literature for original clinical stroke studies conducted in SSA that included PLWH. We included studies that reported data on presenting characteristics, risk factors, and/or outcomes after stroke. Results: Seventeen studies (N = 478) met inclusion criteria. At the time of stroke presentation, PLWH had a median age ranging from 32 to 43 years. Subjects had low CD4 counts (median CD4, 108-225 cells/µl), and most were antiretroviral therapy-naïve. Fever, seizures, and concurrent opportunistic infections were common at presentation. Ischemic stroke accounted for up to 96% of strokes, which were mostly located in the anterior circulation territory. In studies comparing PLWH with HIV-uninfected individuals, PLWH had more frequent coagulopathy, greater stroke severity, (72% versus 36% National Institutes of Health Stroke Scale >13, P =.02), longer hospital length of stay (30.5 versus <10 days), and a higher 30-day mortality rate (23% versus 10.5%, P =.007). Conclusion: Stroke in PLWH in SSA occurs at a young age, in those with advanced disease, and is associated with worse outcomes than in HIV-uninfected comparators. Stroke in young individuals in the region should prompt HIV testing, and ongoing efforts to promote early antiretroviral therapy initiation might also help decrease stroke incidence, morbidity, and mortality in the region.

AB - Background: Human immunodeficiency virus (HIV) infection is associated with worse outcomes after stroke, but this association is less well-described in sub-Saharan Africa (SSA). We reviewed literature on stroke among people living with HIV (PLWH) in SSA. Methods: We systematically reviewed published literature for original clinical stroke studies conducted in SSA that included PLWH. We included studies that reported data on presenting characteristics, risk factors, and/or outcomes after stroke. Results: Seventeen studies (N = 478) met inclusion criteria. At the time of stroke presentation, PLWH had a median age ranging from 32 to 43 years. Subjects had low CD4 counts (median CD4, 108-225 cells/µl), and most were antiretroviral therapy-naïve. Fever, seizures, and concurrent opportunistic infections were common at presentation. Ischemic stroke accounted for up to 96% of strokes, which were mostly located in the anterior circulation territory. In studies comparing PLWH with HIV-uninfected individuals, PLWH had more frequent coagulopathy, greater stroke severity, (72% versus 36% National Institutes of Health Stroke Scale >13, P =.02), longer hospital length of stay (30.5 versus <10 days), and a higher 30-day mortality rate (23% versus 10.5%, P =.007). Conclusion: Stroke in PLWH in SSA occurs at a young age, in those with advanced disease, and is associated with worse outcomes than in HIV-uninfected comparators. Stroke in young individuals in the region should prompt HIV testing, and ongoing efforts to promote early antiretroviral therapy initiation might also help decrease stroke incidence, morbidity, and mortality in the region.

KW - HIV infection

KW - outcomes

KW - risk factors

KW - Stroke

KW - sub-Saharan Africa

UR - http://www.scopus.com/inward/record.url?scp=85045024670&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045024670&partnerID=8YFLogxK

U2 - 10.1016/j.jstrokecerebrovasdis.2018.02.016

DO - 10.1016/j.jstrokecerebrovasdis.2018.02.016

M3 - Article

AN - SCOPUS:85045024670

JO - Journal of Stroke and Cerebrovascular Diseases

JF - Journal of Stroke and Cerebrovascular Diseases

SN - 1052-3057

ER -